Department of Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Spine (Phila Pa 1976). 2010 Sep 15;35(20):E1037-44. doi: 10.1097/BRS.0b013e3181ddd262.
Comparative, prospective follow-up study.
Comparison of outcome between patients treated with Percutaneous VertebroPlasty (PVP) using low and medium viscosity PolyMethylMetAcrylate (PMMA) bone cement.
Viscosity is the characterizing parameter of PMMA bone cement, currently the standard augmentation material in PVP, and influences interdigitation, cement distribution inside the vertebral body, injected volume and extravasation, thereby affecting the clinical outcome of PVP. Currently, low, medium, and high viscosity PMMA bone cements are used interchangeably. However, effect of viscosity on clinical outcome in patients with Osteoporotic Vertebral Compression Fractures (OVCFs) has not yet been explicit subject of investigation.
Follow-up was conducted using a 0 to 10 Pain Intensity Numerical Rating Scale (PI-NRS) and the Short Form 36 (SF-36) Quality of Life questionnaire before PVP and at 7 days (PI-NRS only), 1, 3, and 12 months after PVP. Injected cement volume, degree of interdigitation, and cement leakage were analyzed on direct postoperative computed tomography scanning. At 6 and 52 weeks and at suspicion, patients were analyzed for new fractures.
A total of 30 consecutive patients received PVP using low viscosity PMMA bone cement (OsteoPal-V) for 62 OVCFs, followed by 34 patients who received PVP using medium viscosity PMMA bone cement (Disc-O-Tech) for 67 OVCFs. Results regarding PI-NRS and SF-36 were comparable between both groups. Postoperative comparison of injected cement volume, degree of interdigitation, proportion of bipedicular procedures, incidence of new vertebral fractures and complications revealed no differences between both groups. Viscosity was identified as a risk factor for the occurrence of cement leakage (yes/no, OR: 2.925, 95% confidence interval: [1.072-7.984], P = 0.036).
No major differences in clinical outcome after PVP in OVCFs using low and medium viscosity PMMA bone cement were found. Viscosity of PMMA bone cement was identified as an independent predictor of cement leakage.
比较性、前瞻性随访研究。
比较使用低粘度和中粘度聚甲基丙烯酸甲酯(PMMA)骨水泥进行经皮椎体成形术(PVP)治疗的患者的结果。
粘度是 PMMA 骨水泥的特征参数,目前是 PVP 中的标准增强材料,它会影响骨水泥在椎体内部的相互交织、分布、注射量和外渗,从而影响 PVP 的临床效果。目前,低、中、高粘度 PMMA 骨水泥可互换使用。然而,粘度对骨质疏松性椎体压缩性骨折(OVCF)患者的临床结果的影响尚未成为明确的研究课题。
在 PVP 之前、之后的 7 天(仅 PI-NRS)、1 个月、3 个月和 12 个月,使用 0 到 10 的疼痛强度数字评定量表(PI-NRS)和简明 36 项健康调查量表(SF-36)对患者进行随访。直接术后计算机断层扫描分析注射的骨水泥体积、交织程度和骨水泥渗漏。在 6 周和 52 周以及出现疑似情况时,对患者进行新骨折分析。
共 30 例连续患者接受了低粘度 PMMA 骨水泥(OsteoPal-V)治疗的 62 例 OVCF,随后有 34 例患者接受了中粘度 PMMA 骨水泥(Disc-O-Tech)治疗的 67 例 OVCF。两组患者的 PI-NRS 和 SF-36 结果相似。术后比较两组之间的注射骨水泥体积、交织程度、双侧手术比例、新发椎体骨折发生率和并发症,未发现差异。粘度被确定为骨水泥渗漏发生的危险因素(是/否,OR:2.925,95%置信区间:[1.072-7.984],P = 0.036)。
在使用低粘度和中粘度 PMMA 骨水泥进行 PVP 治疗 OVCF 后,临床结果没有明显差异。PMMA 骨水泥的粘度被确定为骨水泥渗漏的独立预测因子。